Archive: 21/12/2015

Team demonstrates cost-effectiveness of Watchman device

The WATCHMAN Left Atrial Appendage Closure Device is more cost-effective than warfarin and non-warfarin oral anticoagulants (NOACs) for stroke reduction in patients with non-valvular atrial fibrillation, according to a study ...

page 3 from 8